RETRACTION RETRATAÇÃO
[RETRACTED ARTICLE] Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection
Erik Ahlin, PhDI; Amir ElshafeiII; Musa NurIII; Sayda Hassan El SafiIV; Ronnelid JohanV; Gehad ElghazaliVI
IMsc - Immunobiology, Clinical Immunology Unit, Uppsala University, Uppsala, Sweden
IIBachelor of Medicine - Hematology Laboratory of Pathology and Microbiology, Alribat Hospital, Khartoum, Sudan
IIIRheumatologist - Consultant, Unit of Rheumatology, Alribat University Hospital, Khartoum, Sudan
IVProfessor of Immunology - Consultant, Department of Microbiology and Parasitology, Faculty of Medicine, University of Khartoum, Sudan
VAssociate Professor of Immunology - Consultant, Clinical Immunology Unit, Uppsala University, Uppsala, Sweden
VIProfessor of Immunology - Senior Consultant, University of Shendi, Shendi, Sudan; and King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia
ABSTRACT: The Brazilian Journal of Rheumatology (Revista Brasileira de Reumatologia) decided to retract the manuscript entitled Ahlin E, Elshafei A, Nur M, El Safi SH, Johan R, Elghazali G. Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection. Rev Bras Reumatol. 2011 Dec;51(6):579-86.English, Portuguese.
The reasons point out were:
(1)Author Elghazali G did not take part in production the data for the paper and has never been a co-author on any version of the manuscript.M (2) A paper with very similar content, which was part of the PhD thesis of author Ahlin E (first author), was accepted for another journal.
(3) The figures in the paper published in this journal X were identical to the figures in author Ahlin E's PhD thesis.
(4) The name of author Johan Ronnelid was misspelt in the paper published in our journal (RBR) .
The authors E Ahlin, A Elshafei, M Nur and J Ronnelid agreed with the retraction according to the reasons (1, 2, 3, and 4). G Elghazali did not agree and SH El Safi did not respond to our requests.
The retraction is formally approved by the Editors of Revista Brasileira de Reumatologia
São Paulo, April 8, 2014
Editors of the Brazilian journal of Rheumatology
Received on 04/09/2011.
Approved on 08/30/2011.
Authors declare no conflict of interests.
Financial Support: Institutional (university).
Editorial expression of concern
In the December 2011 issue, the Brazilian Journal of Rheumatology published the article: "Anticitrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection" by E. Ahlin, A. Elshafei, M. Nur, S.H. El Safi, R. Johan, and G. Elghazali. [Revista Brasileira de Reumatologia 51, 6 (2011)]. On January 2012, the BJR received a claim from one of the authors, questioning the authorship of the corresponding author, and informed that the article was under submission to another journal, by E. Ahlin, A.I. Elshafie, M.A.M. Nur, and J. Ronnelid. This submission is on hold, the authors were all informed of the claim and the case was submitted to the Committee on Publication Ethics (COPE), which gave some recommendations. The investigation has not yet reached a conclusion. Pending the results of the investigations, BJR is publishing this Editorial Expression of Concern to alert our readers to the fact that serious questions have been raised about the authorship in the Ahlin et al. paper.
Paulo Louzada-Junior and Max Victor Carioca Freitas
Editors-in-chief - Revista Brasileira de Reumatologia
Publication Dates
-
Publication in this collection
08 Apr 2014 -
Date of issue
Dec 2011